|
Dl
Dl
|
Dt
Dt
|
Dc
Dc
|
Dj
Dj
|
Dv
Dv
|
Ds
Ds
|
Dg
Dg
|
|---|---|---|---|---|---|---|
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
1 esdeveniment,
–
Engineering the cancer: from biomaterials to on-chip solutions David Caballero; Research Institute on Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, University of Minho, Portugal. Cancer is a complex and multifaceted pathology, which is influenced by numerous factors, including the tumor microenvironment (TME). This environment is ... Read more |
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
0 esdeveniments,
|
|
0 esdeveniments,
|
0 esdeveniments,
|
1 esdeveniment,
Foregrounding justice, equity and inclusion as determinants of access to precision medicine: an ethical case study of patient-derived tissue organoids. Dr. Ubaka Ogbogu, Professor and the Associate Dean Research in the Faculty of Law from the University of Alberta, Canada. Ubaka Ogbogu is a Professor and the Associate Dean Research in the Faculty of Law. ... Read more |
0 esdeveniments,
|
1 esdeveniment,
–
Modeling immune-cancer interactions using a microfluidic 3D culture approach Charles Baroud, Professor at Ecole Polytechnique, France Lab head at Institut Pasteur, Paris, France Cancer immunotherapy is emerging as a transformative approach for treating cancer patients. This approach, which has shown some remarkable successes, leverages the patient's own immune cells to locate and attack the tumor ... Read more |
0 esdeveniments,
|
0 esdeveniments,
|